Agouron initiates pilot phase II trial of prinomastat as treatment of glioblastoma multiforme Nov. 23, 1999
Pharma Mar isolates marine compound with potent and selective activity against solid tumors Nov. 23, 1999
Preclinical profile of tyrosine kinase inhibitor supports initiation of clinical testing Nov. 23, 1999
CA4P activity reviewed at AACR-NCI-EORTC meeting; Oxigene signs letter of intent with BMS Nov. 23, 1999
1999 AAPS news: Lilly studies PK interactions between LY-335979 and doxorubicin in patients Nov. 22, 1999
RSS